BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

224 related articles for article (PubMed ID: 31973229)

  • 1. Extracellular Vesicles, A Possible Theranostic Platform Strategy for Hepatocellular Carcinoma-An Overview.
    D'Agnano I; Berardi AC
    Cancers (Basel); 2020 Jan; 12(2):. PubMed ID: 31973229
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The role of extracellular vesicles in mediating progression, metastasis and potential treatment of hepatocellular carcinoma.
    Yang N; Li S; Li G; Zhang S; Tang X; Ni S; Jian X; Xu C; Zhu J; Lu M
    Oncotarget; 2017 Jan; 8(2):3683-3695. PubMed ID: 27713136
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Extracellular vesicles as a new hope for diagnosis and therapeutic intervention for hepatocellular carcinoma.
    Nimitrungtawee N; Inmutto N; Chattipakorn SC; Chattipakorn N
    Cancer Med; 2021 Dec; 10(23):8253-8271. PubMed ID: 34708589
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Extracellular Vesicle-Related Non-Coding RNAs in Hepatocellular Carcinoma: An Overview.
    Augello G; Cusimano A; Cervello M; Cusimano A
    Cancers (Basel); 2024 Apr; 16(7):. PubMed ID: 38611093
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Extracellular Vesicles and Hepatocellular Carcinoma: Opportunities and Challenges.
    Wang J; Wang X; Zhang X; Shao T; Luo Y; Wang W; Han Y
    Front Oncol; 2022; 12():884369. PubMed ID: 35692794
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Role of Extracellular Vesicles in Disease Progression and Detection of Hepatocellular Carcinoma.
    Lee YT; Tran BV; Wang JJ; Liang IY; You S; Zhu Y; Agopian VG; Tseng HR; Yang JD
    Cancers (Basel); 2021 Jun; 13(12):. PubMed ID: 34203086
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Locoregional and systemic therapy for hepatocellular carcinoma.
    Gbolahan OB; Schacht MA; Beckley EW; LaRoche TP; O'Neil BH; Pyko M
    J Gastrointest Oncol; 2017 Apr; 8(2):215-228. PubMed ID: 28480062
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Systemic therapy for hepatocellular carcinoma: beyond sorafenib.
    Boland P; Wu J
    Chin Clin Oncol; 2018 Oct; 7(5):50. PubMed ID: 30395717
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Liquid Biopsies in Hepatocellular Carcinoma: Are We Winning?
    Mocan T; Simão AL; Castro RE; Rodrigues CMP; Słomka A; Wang B; Strassburg C; Wöhler A; Willms AG; Kornek M
    J Clin Med; 2020 May; 9(5):. PubMed ID: 32443747
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Extracellular Vesicles-Encapsulated MicroRNA-125b Produced in Genetically Modified Mesenchymal Stromal Cells Inhibits Hepatocellular Carcinoma Cell Proliferation.
    Baldari S; Di Rocco G; Magenta A; Picozza M; Toietta G
    Cells; 2019 Dec; 8(12):. PubMed ID: 31816923
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Treatment of advanced hepatocellular carcinoma: immunotherapy from checkpoint blockade to potential of cellular treatment.
    Siu EH; Chan AW; Chong CC; Chan SL; Lo KW; Cheung ST
    Transl Gastroenterol Hepatol; 2018; 3():89. PubMed ID: 30603725
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacogenetics of the systemic treatment in advanced hepatocellular carcinoma.
    De Mattia E; Cecchin E; Guardascione M; Foltran L; Di Raimo T; Angelini F; D'Andrea M; Toffoli G
    World J Gastroenterol; 2019 Aug; 25(29):3870-3896. PubMed ID: 31413525
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Systemic Therapy for Advanced Hepatocellular Carcinoma: An Update of a Rapidly Evolving Field.
    Doycheva I; Thuluvath PJ
    J Clin Exp Hepatol; 2019; 9(5):588-596. PubMed ID: 31695249
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Advances of multi-omics applications in hepatic precancerous lesions and hepatocellular carcinoma: The role of extracellular vesicles.
    Lu X; Li Y; Li Y; Zhang X; Shi J; Feng H; Gao Y; Yu Z
    Front Mol Biosci; 2023; 10():1114594. PubMed ID: 37006626
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Extracellular Vesicles Act as Carriers for Cargo Delivery and Regulate Wnt Signaling in the Hepatocellular Carcinoma Tumor Microenvironment.
    He R; Xu Y; Yu L; Meng N; Wang H; Cui Y; Yam JWP
    Cancers (Basel); 2023 Mar; 15(7):. PubMed ID: 37046749
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Role of anti-angiogenesis therapy in the management of hepatocellular carcinoma: The jury is still out.
    Sun H; Zhu MS; Wu WR; Shi XD; Xu LB
    World J Hepatol; 2014 Dec; 6(12):830-5. PubMed ID: 25544869
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Extracellular Vesicles as Potential Theranostic Platforms for Skin Diseases and Aging.
    Kim H; Lee JW; Han G; Kim K; Yang Y; Kim SH
    Pharmaceutics; 2021 May; 13(5):. PubMed ID: 34065468
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Chemotherapy for hepatocellular carcinoma: current status and future perspectives.
    Ikeda M; Morizane C; Ueno M; Okusaka T; Ishii H; Furuse J
    Jpn J Clin Oncol; 2018 Feb; 48(2):103-114. PubMed ID: 29253194
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Systemic treatment of hepatocellular carcinoma: from sorafenib to combination therapies.
    Roderburg C; Özdirik B; Wree A; Demir M; Tacke F
    Hepat Oncol; 2020 May; 7(2):HEP20. PubMed ID: 32647565
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Systemic treatment of advanced hepatocellular cancer: new hope on the horizon.
    Chang Lee R; Tebbutt N
    Expert Rev Anticancer Ther; 2019 Apr; 19(4):343-353. PubMed ID: 30793991
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.